ECI sells CliniSys

Read Time: 1 Min

CliniSys Group logo

We are delighted to announce that the sale of CliniSys completed on Thursday 4 July 2013 in a secondary sale. The exit has yielded ECI a 2.5x return on its investment.

Based in Chertsey, and with offices in Germany, France, Belgium and Spain, CliniSys is the European market leading provider of software solutions to clinical laboratories across Europe. The Company’s laboratory information systems help customers deliver timely and accurate test results to a wide range of constituents across the healthcare delivery chain. Solutions have been successfully deployed in over 2,000 laboratories with more than 22,000 users in 34 countries.

Technological advances, the emergence of personalized medicine and ageing populations are all boosting demand for clinical laboratory services, in turn driving a need for the efficiencies that CliniSys’ systems can provide. CliniSys is forecasting revenues of over £34 million for the current year, an increase of over 50% since ECI invested.

‘Under ECI’s ownership CliniSys has increased sales, profits and headcount. The company is now the European market leader in laboratory information systems, and its transformation is all thanks to the hard work of Fiona and her team.

‘We wish CliniSys every success in the future as it embarks on its next stage of growth and development with Montagu.

‘Today’s sale represents another successful transaction for ECI, and highlights our strong track record in and commitment to building international market leading businesses in the TMT sector.’

Tom Wrenn 

the partner who heads ECI’s TMT sector

Download the press release here


About the author

Tom Wrenn

"I’m one of the four Managing Partners at ECI who make up our Investment Committee and run the firm. I’ve spent most of my career working with tech and tech enabled businesses helping them to achieve their global growth ambitions whether organically or via M&A."

View Full Profile